'

RPG Life sciences hosted a conference call on May 2, 2024. In the conference call, the company was represented by Mr Vishal shah- CFO and Mr Yugal Sikri- Managing director.

Key takeaways of the call

Domestic Formulations, the biggest contributor to the company’s business, recorded 15% YoY sales growth in FY24. The company registered growth in both value and volume - significantly and consistently ahead of the market based on its 5 pillar-growth strategy.

Company’s new products contribution in domestic formulations business improved consistently (currently >25%) because of new launches in specialty & chronic segments and line extensions of legacy products.

The company intends to enter other specialties like Gastro and Derma, which will emerge as future growth drivers of domestic formulations business.

The International formulations business regis...

• 

  (10-Feb-2023)

  Deepak Nitrite

  Plans capex of about Rs 1500 crore for FY23 and FY24

• 

  (09-Feb-2023)

  Mayur Uniquoters

  Targets revenue of Rs 1000 crore in FY24

• 

  (31-Jan-2023)

  Tega industries

  Capex plan is US$ 30-32 million for next three years

• 

  (15-Dec-2021)

  ITC

  Company plans capex of Rs 10,000 crore over the next three years to create growth vectors